Escolha sua fonte:
 Arimo
 Merriweather
 Mukta Malar
 Open Sans Condensed
 Rokkitt
 Source Sans Pro
 Login


 Português 
 Français 
 English 
 Español 

[Valid RSS] RSS
bar

Banco de dados - (CIANE)

Descrição deste banco de dados documental (Site da CIANE)
Atualmente 3108 fichas
Canal do YouTube (tutorial)

https://ciane.net/id=2330

Criado em : 18 Dec 2009
Alterado em : 18 Dec 2009

 Modificar esta ficha
Siga este link somente se você tiver um palavra chave de editor!


Compartilhar: Facebook logo   Tweeter logo   Fácil

Nota bibliográfica (sem autor) :

Systematic Underfunding of Research and Development in Maternal and Perinatal Health. Special Report to the Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN). Published simultaneously in Journal of Midwifery and Women’s Health 2009;54(5)

Autores :

R. Rima Jolivet

Ano de publicação :

2009

URL(s) :

http://www3.interscience.wiley.com/journal/1216422…
https://doi.org/10.1111/j.1471-0528.2008.02027.x

Résumé (français)  :

Cet article révèle une déficience systématique du financement de la recherche (publique et privée) dans le domaine de la santé maternelle et périnatale. Il couvre le Royaume-Uni, l’Union européenne, les USA, le Canada, l’Australie, l’Inde, et l’Afrique du Sud.

Bien que les problèmes de santé maternelle et périnatale soient au premier plan des problèmes de santé en général, la proportion du financement qui leur est accordé est dans une fourchette de moins de 1% à 4% dans les pays couverts par l’étude.

Abstract (English)  :

Several recent publications point to evidence of
systematic underfunding of research and development
in maternal and perinatal health. This gross
underrepresentation on research budgets persists
worldwide despite the push for greater focus on
health improvements for mothers and babies in
public health goals from major national and
international organizations, including the United
Nations Millennium Development Goals and
Healthy People 2010.

Fisk and Atun (2009) conducted a systematic review
of funding for maternal and perinatal clinical
research in the United Kingdom, the European Union,
the United States, Canada, Australia, India and
South Africa, looking at both governmental and
philanthropic funding. They report that although
maternal and perinatal conditions are the single
largest contributor by category to the global disease
burden, the proportion of total spending
allocated to maternal and perinatal research in the
countries studied ranged from < 1% to 4% of all
health research funding.

These findings are mirrored in the same authors’
earlier analysis of funding by the global pharmaceutical
industry for research and development of
new drugs for use in pregnancy (Fisk & Atun,
2008). Here, the authors found that despite the fact
that 3/4 of the world’s 4500,000 maternal deaths
are attributable to preventable or treatable conditions,
only one new class of drug licensed in the
last 20 years was primarily for obstetric use, and
only 17 drugs were under active development for
maternal health indications at the time of their
assessment.

Lyerly, Little and Faden (2008) point out that in the
United States, two-thirds of women take 4 to 5 medications
during pregnancy, and of the over 4 million
pregnancies each year in this country, 1% are complicated
by hypertension or diabetes, and > 10% by
psychiatric illness. Virtually all medications taken
during pregnancy are prescribed ‘‘off-label’’, i.e.,
without approval by the Food and Drug Administration
for use in pregnancy. This means that there are
no data on their safety or e/cacy or information to
guide dosing regimens in pregnancy.

The Institute of
Medicine 1994 report, Women and Health Research:
Ethical and Legal Implications of Including
Women in Clinical Studies, strongly recommended
clinical research to advance the medical management
of diseases of pregnancy, and conditions that
threaten the outcomes of pregnancy. However, 15
years after the release of that report, the health
and safety of pregnant women and their infants remain
poorly addressed and sorely neglected on the
health research agenda. The recent heightened
focus on comparative electiveness research presents
an opportunity to address some of the
established research gaps relating to maternal and
newborn health.

Sumário (português)  :

Resumen (español)  :

Texto completo (private) :

 ➡ Acesso requer autorização

Comentários :

Argument (français) :

Bien que les problèmes de santé maternelle et périnatale soient au premier plan des problèmes de santé en général, la proportion du financement qui leur est accordé est dans une fourchette de moins de 1% à 4%

Argument (English):

Argumento (português):

Argumento (español):

Palavras-chaves :

➡ saúde pública

Autor da esta ficha :

Bernard Bel — 18 Dec 2009

Discussão (exibir apenas português)
 
➡ Reservado para usuários identificados



 Li a carta de discussões e aceito as condições (leia as diretrizes)

barre

Efectuar uma nova consulta especialista --- Outro pedido simples

Criação de uma ficha --- Importar registros

Gerenciamento de usuários --- Fazer backup do banco de dados --- Contato

bar

Esta base de dados criada pela Alliance francophone pour l'accouchement respecté (AFAR) é gerida
pela Collectif interassociatif autour de la naissance (CIANE, https://ciane.net).
Ele é alimentado pelas contribuições de voluntários interessados ​​em compartilhar informações científicas.
Se você aprovar este projeto, você pode nos ajudar de várias maneiras:
(1) tornar-se um colaborador com base nisso, se você tem um pouco experiência na literatura científica
(2) ou apoio financeiro CIANE (veja abaixo)
(3) ou tornar-se um membro da outra associação afiliada à CIANE.
Faça login ou crie uma conta para seguir as alterações ou se tornar um editor.
Contato bibli(arobase)ciane.net para mais informações.

Valid CSS! Valid HTML!
Doar para a CIANE (clique em “Faire un don”) nos ajudará a manter e desenvolver sites e bancos de dados
públicos para o apoio das decisões informadas dos pais e cuidadores com relação ao parto